Drug profile · INN
trimethadione
TRIDIONE
trimethadione (TRIDIONE) is a voltage-gated t-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — trimethadione
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
trimethadione (TRIDIONE) is a voltage-gated t-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated T-type calcium channel blocker
Primary target: Voltage-gated T-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trimethadione?
trimethadione (TRIDIONE) is a voltage-gated t-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trimethadione?
TRIDIONE is a marketed brand name for trimethadione. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trimethadione?
trimethadione has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.